First Time Loading...

CSL Ltd
ASX:CSL

Watchlist Manager
CSL Ltd Logo
CSL Ltd
ASX:CSL
Watchlist
Price: 279.92 AUD 0.27% Market Closed
Updated: May 13, 2024

CSL Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CSL Ltd
Cost of Revenue Peer Comparison

Comparables:
IMM
OPT
MSB
CUV
TLX

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
CSL Ltd
ASX:CSL
Cost of Revenue
-$6.9B
CAGR 3-Years
-19%
CAGR 5-Years
-14%
CAGR 10-Years
-11%
Immutep Ltd
ASX:IMM
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Opthea Ltd
ASX:OPT
Cost of Revenue
-$233.9k
CAGR 3-Years
18%
CAGR 5-Years
3%
CAGR 10-Years
10%
Mesoblast Ltd
ASX:MSB
Cost of Revenue
-$21.7m
CAGR 3-Years
15%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Cost of Revenue
AU$8.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Telix Pharmaceuticals Ltd
ASX:TLX
Cost of Revenue
-AU$188.2m
CAGR 3-Years
-353%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is CSL Ltd's Cost of Revenue?
Cost of Revenue
-6.9B USD

Based on the financial report for Dec 31, 2023, CSL Ltd's Cost of Revenue amounts to -6.9B USD.

What is CSL Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-11%

Over the last year, the Cost of Revenue growth was -23%. The average annual Cost of Revenue growth rates for CSL Ltd have been -19% over the past three years , -14% over the past five years , and -11% over the past ten years .